The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Workforce
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Neutrophil Extracellular Traps & Their Role in Autoimmunity

Neutrophil Extracellular Traps & Their Role in Autoimmunity

May 18, 2018 • By Kathy Holliman

  • Tweet
  • Email
Print-Friendly Version / Save PDF
A neutrophil in a blood smear.

A neutrophil in a blood smear.
Jarun Ontakrai / shutterstock.com

Certain medications have been associated for decades with the development of drug-induced autoimmunity. New research published in March 2018 in Arthritis & Rheumatology suggests that NETs (neutro­phil extracellular traps) are potentially implicated in the mechanisms that lead to drug-induced autoimmunity.1

You Might Also Like
  • Rheumatology Researchers Explore Role of Neutrophils in Autoimmunity
  • Controlled Neutrophil Production Could Improve Immunometabolism
  • Extracellular Vesicles May Play an Important Role in Seropositive RA Disease Severity
Explore This Issue
May 2018
Also By This Author
  • Pain Linked to Inflammatory Lesions in Knee Osteoarthritis

Peter Grayson, MD, MSc, head of the Vasculitis Translational Research Program at the National Institute of Arthritis and Musculoskeletal and Skin Diseases, says that research related to NETs may have no current clinical implications, but he predicts that research focused on NETs “is likely to unlock novel therapeutic strategies in a range of rheumatologic diseases.” Understanding the role of NETs in drug-induced autoimmunity may be the next step toward clarifying the mechanisms of autoimmunity.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

NET formation is involved in the neutro­phil cell death process, called NETosis, which is different morphologically from other types of cell death, including apoptosis and necrosis. In NETosis, the dying neutrophils “can unwind their DNA and launch it out of the cell like a spiderweb to engulf and facilitate the elimination of pathogens,” Dr. Grayson explains. The process, however, can become aberrant in many rheumatologic diseases with the dysregulation of NET formation.

“What is surprising and potentially interesting for rheumatologists to understand is that there is only a small number of proteins inside these NETs, and many of them are the antigenic targets of autoantibodies in rheumatologic diseases,” Dr. Grayson says. Patients with rheumatoid arthritis make anticyclic citrullinated peptide (CCP) antibodies directed to proteins found in the NETs. Patients with lupus make antibodies to NET components. Proteinase 3 and myeloperoxidase, the antigenic targets of antineutrophil cytoplasmic antibodies (ANCA) are commonly found within NETs.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

“These proteins that are normally hidden inside a neutrophil get exposed to the adaptive immune system in a way that is immunogenic, which then can potentially lead to development of antibodies to those proteins,” says Dr. Grayson.

NET formation and impaired NET degradation have been implicated in the pathogenesis of both systemic lupus erythe­matosus (SLE) and ANCA-associated vasculitis (AAV). “The process of NETosis may contribute to causal mechanisms of disease in rheumatoid arthritis, lupus and AAV,” he says.

In NETosis, the dying neutrophils ‘can unwind their DNA & launch it out of the cell like a spiderweb to engulf & facilitate the elimination of pathogens,’ Dr. Grayson explains.

Triggering NET Formation, Degradation

Previous research that examined drug-induced autoimmunity looked at the effect of medications on lymphocytes. This new research by Dr. Grayson and colleagues looked at their effect on neutrophils and NETs. Medications associated with drug-induced autoimmunity can lead to development of a rheumatologic disease that “has a specific look or feel to it. It looks a lot like lupus mixed with ANCA vasculitis. We thought that because NETs are important in lupus and ANCA vasculitis, maybe the drugs are inducing NETs, since it’s a common theme to those conditions,” Dr. Grayson explains.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Pages: 1 2 3 | Single Page

Filed Under: Conditions, Drug Updates Tagged With: neutrophil extracellular trapsIssue: May 2018

You Might Also Like:
  • Rheumatology Researchers Explore Role of Neutrophils in Autoimmunity
  • Controlled Neutrophil Production Could Improve Immunometabolism
  • Extracellular Vesicles May Play an Important Role in Seropositive RA Disease Severity
  • Rheumatology Research Foundation Grant Aids Investigations Into Rheumatoid Arthritis

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.